MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. ADVANCE II MODULAR TITANIUM TIBIAL BASE SZ 3+ POR; KNEE COMPONENT

Model Number KTTIPC31

Device Problem Unstable (1667)

Patient Problem No Information (3190)

Event Type  Injury  

Manufacturer Narrative

This event will be updated once the investigation is complete.Trends will be evaluated.

Event Description

Allegedly, patient is having instability problems in his right knee.

• Brand Name: ADVANCE II MODULAR TITANIUM TIBIAL BASE SZ 3+ POR
• Type of Device: KNEE COMPONENT
• Manufacturer (Section D): MICROPORT ORTHOPEDICS INC.; 5677 airline rd.; arlington TN 38002
• Manufacturer (Section G): MICROPORT ORTHOPEDICS INC.; 5677 airline rd.; arlington TN 38002
• Manufacturer Contact: 5677 airline road; arlington, TN 38002 ; 9018674771
• MDR Report Key: 9787687
• MDR Text Key: 182007660
• Report Number: 3010536692-2020-00181
• Device Sequence Number: 1
• Product Code: HRY
• UDI-Device Identifier: M684KTTIPC311
• UDI-Public: M684KTTIPC311
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: K061223
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: foreign
• Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date: 09/21/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Other
• Device Model Number: KTTIPC31
• Device Catalogue Number: KTTIPC31
• Device Lot Number: 091A145628
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Distributor Facility Aware Date: 02/12/2020
• Initial Date Manufacturer Received: 02/12/2020
• Initial Date FDA Received: 03/04/2020
• Supplement Dates Manufacturer Received: 02/12/2020
• Supplement Dates FDA Received: 09/21/2020
• Is the Device Single Use?: Yes
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Required Intervention